Page 1


Community Pharmacy News – May 2018

PSNC sets out vision for future contract

Proposals for care framework and care plan service would reward community pharmacies for offering patient care Funding statement | Support with GDPR compliance | Prescription submission factsheet




Community pharmacy must not be divided Simon Dukes took over as Chief Executive of PSNC on May 1st. Here he shares some first impressions of community pharmacy and the opportunities ahead. to any sector, “oneAsofa newcomer the most valuable things you can offer is a reality check for those already working in it. For many community pharmacies, I can see that the reality is tough. I have been struck by just how isolating and uncertain it must feel for many of you working in an environment of funding cuts and with no clear idea of what the future might hold.

I have also been struck by the sense of exasperation – evident across community pharmacy – with the Government, and I can understand that. Government can feel impenetrable from the inside, let alone for those trying to work with it from the outside. In my experience you cannot negotiate with people you do not know; so building relationships with key people within Government will be the absolute priority for me and my team.

But I am optimistic for that future. Community pharmacies are vital for so many patients, acting as their access point to the NHS. That is a hugely important function within society and changing it would be unthinkable.

My most recent background is working in data and technology and that too is an important area for community pharmacy – we must make use of the powerful data that we have to support our arguments. We need also to think more about strategic influencing – yes, the Pharmacy Minister is important, but who else can we talk to who might help us to make our case for change? I will bang on doors to make things happen, but it will be even more powerful if we can get other people from outside the sector doing that on our behalf as well.

I have already been impressed by the expertise and dedication of the staff and members of PSNC, and my job now is to harness that to support pharmacies and the LPCs who represent you locally. We must work together, because however fragmented the sector may seem at times, community pharmacy cannot allow itself to be divided. Unpicking the complexity and working collaboratively with other community pharmacy organisations will be a key focus for me.

Just two weeks into the job I have been delighted by the approachability of everyone at PSNC, and across pharmacy. Thank you to everyone who has already been in touch; I am speaking, but more importantly, listening, to as many of you as possible and looking forward to spending some time in pharmacies. I can see that the role of PSNC and in particular the support that it offers to all pharmacies is absolutely crucial, and my aim is to channel the wealth of experience that we have here to do just that.

Simon Dukes, PSNC Chief Executive

May PSNC meeting At PSNC’s May meeting, key topics included a funding update, the 2018/19 flu season and the General Data Protection Regulation (GDPR). A summary for contractors will be available to download from the PSNC website.

PSNC training events PSNC regularly runs training sessions for LPCs and community pharmacy teams; here are two of our upcoming events. Endorsing Good Practice Guidance PSNC’s Dispensing and Supply Team will be holding an Endorsing Webinar, on Tuesday 12th June at 7.30pm, where our in-house Drug Tariff experts will talk you through the dos and don’ts of endorsing your prescriptions.

Preparing Bids and Business Cases To help community pharmacy navigate new commissioning structures such as Sustainability and Transformation Partnerships (STPs), PSNC is running workshops on local service development in June 2018.

The team will guide you through a series of sample prescriptions as seen by the PSNC Pricing Audit Centre and the NHS Business Services Authority and will also be answering your endorsement-related questions at the end of the webinar.

The workshops will provide an introduction to local commissioners and outline what community pharmacy can offer, as well as examining how best to prepare bids and business cases. Members of the community pharmacy team who are keen to expand the range of local services from their pharmacy and increase income are welcome to attend.

Please visit to sign up.

Find out more at:

2 Community Pharmacy News – May 2018





PSNC Statement on Community Pharmacy Funding Negotiations Pharmacy Minister interested to hear about community pharmacy and the management of long-term conditions. The Chair of the All-Party Pharmacy Group (APPG), Sir Kevin Barron MP, has made a statement on the upcoming negotiations on community pharmacy funding following correspondence with Pharmacy Minister Steve Brine.

PSNC statement

The Minister said he had been very interested in the APPG’s work hearing evidence on community pharmacy and the management of long-term conditions and he noted PSNC’s proposals for the development of community pharmacy services. PSNC discussed proposals for the future of the Community Pharmacy Contractual Framework at its January meeting and these were put to the Department of Health and Social Care (DHSC) and NHS England. Further details on PSNC’s proposals can be found below.

There is currently no mandate for the negotiations on funding for the 2018/19 financial year from NHS England and the DHSC, but PSNC hopes these discussions will begin soon.

“Our ambition is to move to a funding framework that fairly rewards community pharmacies for offering a wide range of patient care and services including the dispensing of medicines. This is in line with the sector’s shared vision for its future, and would include allowing pharmacies to offer more patient care, particularly for people with long-term conditions. The Minister has given no detail on what the substance of our negotiations with the DHSC and NHS England for 2018/19 will be, but we hope that we will be able to have substantive discussions on the future of community pharmacy. Given the very difficult financial situation that many community pharmacy contractors now find themselves in it is vital that we start to make meaningful progress towards achieving the sector’s vision.”

The Community Pharmacy Care Proposals PSNC has developed a set of proposals for the development of community pharmacy’s role in caring for people with long-term conditions. The service developments PSNC envisages would support both the implementation of the proposals set out in the Community Pharmacy Forward View and the Murray Review’s recommendation to modernise the MUR service. They are also aligned to the policies set out in the NHS England Five Year Forward View Next Steps document and the aims of NHS England’s Medicines Value Programme. PSNC’s proposals are intended to provide a possible mechanism to move towards a community pharmacy funding arrangement that fairly rewards community pharmacies for providing more patient care and support for people with long-term conditions. A briefing, infographics and a PowerPoint presentation which help to explain PSNC’s proposals can be found at: 3




GDPR Action Needed: Appointing a Data Protection Officer All community pharmacy contractors are now advised to start making arrangements to appoint a Data Protection Officer. PSNC is advising community pharmacy contractors to start making plans to appoint a Data Protection Officer (DPO), because it is likely that the UK Data Protection Act 2018 will require this. On 9th May the Minister for Digital and the Creative Industries, Margot James MP, told the House of Commons that as primary care providers “process sizeable quantities of sensitive health data” then they should have “a single point of contact on data protection matters”. This followed campaigning by PSNC, the NPA and other primary care representatives, working with some MPs, to try to secure an amendment to the draft UK data protection legislation that would have meant that smaller pharmacies did not necessarily need to appoint a DPO. Therefore, whilst in the Guidance for Community Pharmacy (Part 1), we advised that community pharmacies ‘may also need to appoint a DPO’, PSNC must now advise that all contractors appoint a DPO as part of their journey towards compliance with the General Data Protection Regulation (GDPR) and the associated (currently draft) UK Data Protection Act 2018.

Time constraint concerns There is now very little time before 25th May 2018, the day the GDPR comes into force and the likely day on which the Data Protection Act 2018 comes into force. However, as has been said in the Guidance for Community Pharmacy (Part 1): If you are worried about getting everything done in time, two quotes from the Information Commissioner Elizabeth Denham’s blog may reassure you: “GDPR compliance will be an ongoing journey”; and “… if you can demonstrate that you have the appropriate systems and thinking in place you will find the ICO to be a proactive and pragmatic regulator aware of business needs and the real world”. Informally, the message from those involved with GDPR is that they are not expecting everybody to be fully compliant with GDPR on 25th May 2018, not least because the UK legislation is not yet in place.

Selecting a DPO To meet the DPO requirement, contractors can either appoint a member of staff or an external person, perhaps shared with other community pharmacies locally. The Community Pharmacy GDPR Working Party will issue further guidance, as will the NPA, which has agreed to lead on the issue for its members. The DPO may be a pharmacist or another suitable person with knowledge of the particular community pharmacy and ‘expert’ knowledge of data protection and the GDPR and associated legislation, as this relates to that community pharmacy (for example, has a thorough understanding of the guidance issued by the Community Pharmacy GDPR Working Party, as well as the ICO and IGA guidance on the role of the DPO). The DPO is primarily an advisory role, although the DPO’s name is stated on the Privacy Notice and, therefore, may be the first person to be contacted by patients about data protection issues and data subject rights. The DPO must not be a person who decides the purposes and means of processing, the person who decides the operational issues on data flows.

4 Community Pharmacy News – May 2018

For now, contractors should consider the following details provided by the Information Commissioner’s Office (ICO):   DPOs assist you to monitor internal compliance, inform and advise on your data protection obligations, provide advice regarding Data Protection Impact Assessments (DPIAs) and act as a contact point for data subjects and the supervisory authority.    The DPO must be independent, an expert in data protection, adequately resourced, and report to the highest management level.    A DPO can be an existing employee or externally appointed.    In some cases, several organisations can appoint a single DPO between them.    DPOs can help you demonstrate compliance and are part of the enhanced focus on accountability. Further guidance on the role of the DPO is available from the ICO and NHS Digital’s Information Governance Alliance (IGA).






Helping you prepare for GDPR Make sure your pharmacy is ready for the incoming General Data Protection Regulation (GDPR) and associated legislation by using the guidance available from PSNC. Your GDPR checklist

Getting to grips with GDPR

Additional information

The mnemonic ‘DATA PROTECTED’ can help community pharmacy contractors remember the 13 steps needed to comply with the GDPR. Here is your checklist of actions:   Decide who is responsible   Action plan*   Think about and record the personal data you process   Assure your lawful basis for processing   Process according to data protection principles   Review and check with your processors   Obtain consent if you need to   Tell people about your processes: the Privacy Notice   Ensure data security   Consider personal data breaches   Think about data subject rights   Ensure privacy by design and default   Data protection impact assessment

This series of articles, written by PSNC Director of Operations and Support Gordon Hockey, accompanies the GDPR guidance and contractor workbook.

PSNC also wishes to clarify two issues in the Workbook for Community Pharmacy.

Articles published so far include: 1. Where do I start? – introducing the legislation. 2. Have a plan! – helping you to get organised. 3 and 4. Your lawful basis for processing personal data – identifying the legitimate reasons that pharmacies have for handling data. 5. Process according to data protection principles – describing how you should process personal data. 6. Review and check with your processors – checking your contracts meet GDPR requirements. 7. Consent – clarifying the impact GDPR has on consent for community pharmacy.

1. Template A: Decide who is responsible – the Caldicott Guardian It is not mandatory for contractors to appoint a registered Caldicott Guardian, though they may choose to do so if this makes sense for their organisation. There should be somebody at a high level within the organisation (perhaps the IG Lead) who takes responsibility for protecting the confidentiality of service users’ health and care data and making sure that it is used appropriately.

*Contractors are recommended to use the one available in the Workbook for Community Pharmacy, which is downloadable from

Further articles will be published between now and the end of the month, and links to all the articles will be available from:

Complying with GDPR webinar A recorded version of PSNC’s recent webinar on GPR compliance is available at: The on-demand webinar explains what the GDPR means for the average pharmacy business and outlines the steps contractors will need to take to comply.

2. Template D: Data Protection Impact Assessment (DPIA) Community pharmacies processing data concerning health on a largescale must carry out a DPIA but the interpretation of large-scale remains unclear. Therefore, we will shortly be issuing a DPIA template which we recommend that all contractors, including smaller community pharmacies, complete as part of preparations for GDPR compliance. Look out for this on the PSNC website.

National data opt-out system for patients NHS Digital is developing a national data opt-out system to give patients the opportunity to stop their personal identifiable information from being used for research and planning purposes. The patient-facing web link for the system is scheduled to go live on 25th May 2018. After the release of the system, community pharmacy contractors are advised to signpost patients that ask about the opt-out to the patient-facing website where patients will be able to read more information or call NHS Digital. For more information please visit: 5




New guidance and resources available for Quality Payments A range of materials have been published to support community pharmacy contractors in meeting the gateway and quality criteria for the 2018/19 Quality Payments Scheme. NHS England guidance NHS England has published guidance on the Quality Payments Scheme for the June 2018 review point. The guidance document considers learnings from the November 2017 declaration, the validation procedures and the subsequent modifications that have been made to processes for the June 2018 declaration. It also clarifies the requirements for meeting the gateway and quality criteria, completing the June 2018 declaration process and where possible, the evidence required to meet the validation procedures. The new guidance should be read in conjunction with the previously published NHS England guidance on the gateway and quality criteria. Links to all the guidance documents can be found at:

Evidence checklist

PSNC video

PSNC has developed a checklist giving examples of what constitutes acceptable evidence for meeting the gateway and quality criteria. It is important that contractors have this evidence to assure themselves that they meet all the requirements; as well as to be able to provide this evidence to the NHS Business Services Authority provider assurance team that will undertake verification checks on behalf of NHS England to ensure that these requirements are met. Find the checklist at:

Zainab Al-Kharsan, Service Development Pharmacist at PSNC, has recorded a six-minute video presentation summarising the changes that have been made for the June 2018 review point. Watch it now at: qualitywebinar

Overview of PSNC resources

Key points

PharmOutcomes support Support available on the PharmOutcomes platform includes a framework to help track progress with achieving the Quality Payment criteria, as well as an asthma referral tool to help with meeting that specific criterion. Find out more about this support, which has been made available to all contractors, at: LPCs can access data on local contractors who are using the PharmOutcomes tool for Quality Payments via their LPC dashboard.

PSNC Briefing 027/18 provides a list of all the PSNC resources available to contractors to assist them with meeting the gateway and quality criteria for the June 2018 review point. Find the briefing at:

NHS Choices user guides NHS Choices has published user guides explaining how to update NHS Choices profiles and how to upload the Community Pharmacy Patient Questionnaire. These are available on the NHS Choices website; links available at:

Updated NUMSAS toolkit published NHS England has published an updated and shorter version of the NHS Urgent Medicine Supply Advanced Service (NUMSAS) toolkit, to reflect the extension of the service until the end of September 2018. In March 2018, NHS England also published an updated service specification and the Department of Health and Social Care issued accompanying Secretary of State Directions which came into effect on 30th March 2018. All the updated documentation is available at:

6 Community Pharmacy News – May 2018





Pharmacies tackle inequalities for patients with psychosis Project in Barking and Dagenham finds that community pharmacy teams can help improve physical health for people with a mental health condition. A community pharmacy service, Improving Physical Health Care for People with Psychosis (PHCP), has been highlighted by the Royal College of Psychiatrists as an example of good practice using Quality Improvement methodologies to improve patient outcomes. The project, which took place in Barking and Dagenham, involved patients with a diagnosis of psychotic illness being offered physical health checks at a local participating community pharmacy. This included ECG, blood pressure, cholesterol and glucose testing with results available on the same day.

350 patients were eligible for the service 70% of attendees had all five Lester cardiometabolic risk factors monitored

Almost four-fifths of those offered health checks took up the offer Pharmacies achieved a higher rate of patient uptake compared to other health settings

factors compared to the averages seen in other health settings. All patients attending community pharmacy health checks had health coaching to support them with physical health, in comparison to 44% of patients receiving standard care in Barking and Dagenham. Pharmacists spent up to an hour coaching patients and empowering them to self-manage their physical health.

This joint collaboration between North East London LPC, North East London NHS Foundation Trust (NELFT) and University College London was funded by a Health Foundation Innovation Award and ran from September 2016 to January 2018.

Out of the 180 eligible patients that were offered health checks, 140 attended with 78% who were offered the health checks taking up the offer. Community pharmacy teams also achieved a higher rate of patient uptake for monitoring of all five Lester cardiometabolic risk

The project team and NELFT are now considering how to implement the PHCP model across the four London Boroughs within the Trust’s area. Learn more about the project at:

New series of gateway pages launched The Centre for Pharmacy Postgraduate Education (CPPE) has created a series of webpages linking to associated learning materials on a topic to assist the learning process. CPPE has launched “a set of new gateway pages on the website, designed to make the entire CPPE portfolio Ange Brennan, of learning materials more accessible and Deputy editor, CPPE user-friendly.

topic, details of related CPPE learning programmes and links to external resources. Through each page you can improve your knowledge and skills and contribute to your CPD by booking workshops, completing e-assessments, undertaking e-learning and accessing tools to support your learning and practice, all in one place on the CPPE website.

The gateway pages are organised into three categories – NHS priorities, Clinical pharmacy and Public health. You can access these pages from the CPPE homepage using the drop-down menu in the top blue bar of the page, where the three categories of pages are listed. There are a wide range of topics covered with their own page.

We have developed new learning material specifically for our gateway pages. These quizzes and individual case studies will allow you to easily engage with a topic area, meaning that you can continue to increase your knowledge and understanding in a variety of different pharmacy areas.

Each of these individual gateway pages contain an introduction to the

The gateway pages keeps a record of the material that you have accessed whilst

you are logged into the CPPE website, meaning you can keep track of their learning across all of the pages. Have a look at a selection of our gateway pages: •   Antimicrobial resistance (https://www.; •   Patient safety (https://www.cppe.; •   Biochemistry ( gateway/BioChem); and •   Substance misuse (https://www.cppe. These pages, and many more, are all accessible from the CPPE homepage. Even more gateway pages are in development. Keep an eye on the CPPE website for new pages which will become available in the coming months. 7




Dispensing and Supply News Our Dispensing and Supply Team highlights the latest news, information and guidance that community pharmacy teams should be aware of. Valproate licence change The Medicines and Healthcare products Regulatory Agency (MHRA) has changed the licence for valproate medicines (Epilim, Depakote and generic brands) so it must no longer be prescribed to women or girls of childbearing potential unless they are on the Pregnancy Prevention Programme (PPP). Further information, including links to resources, can be found at: Hints & Tips newsletter We would like to draw your attention to the latest edition (Issue 31) of the Pricing Authority’s Hints & Tips for dispensing contractors newsletter. It contains some really useful information and advice on the increase in checks on claims for

free NHS prescriptions and helping your patients understand the impact of GDPR, plus much more. All editions of the Hints & Tips newsletter can be found at: Problems obtaining a medicine or appliance? Community pharmacy teams who experience problems in obtaining medicines or appliances are reminded to feed this back to PSNC’s Dispensing and Supply Team. PSNC reports the feedback received to the Department of Health and Social Care to support their monitoring of the situation. It is also used in discussions with manufacturers, for example,

highlighting problems with contingency arrangements. Please report using our online feedback forms: Prescription Submission Factsheet Preparing the monthly submission bundle is an important task for pharmacy teams so PSNC’s Dispensing and Supply Team has created a factsheet full of tips and advice on endorsing and submitting prescriptions for payment. The factsheet is on pages 9 and 10 of this month’s CPN magazine and can also be downloaded as a standalone sheet from the PSNC website.

Ask PSNC Questions that the PSNC Dispensing and Supply Team has been asked recently include: 1. I have received an FP10 prescription for two pairs of Thigh Stockings - Class 2. How many prescription charges should the patient pay and how many dispensing fees can I claim? Prescription charges for elastic hosiery are calculated per garment (2 pairs of stockings = 4 garments) but professional fees are calculated per prescription item (2 pairs of stockings = 1 prescription item), therefore two pairs of stockings would incur four patient charges. The contractor would receive one dispensing fee. Note: Lymphoedema garments are not hosiery, and as such, where more than one lymphoedema garment of the same type is supplied, only one prescription charge should be levied (e.g. Jobst Elvarex Custom Fit Class 1 Thigh High Stockings would incur just one prescription charge). 2. I have a prescription for Sigvaris Comfort class 1 below knee open toe normal and Sigvaris Comfort class 2 below knee open toe normal lymphoedema garments; how many prescription charges will apply? Two prescription charges will apply. Multiple prescription charges for lymphoedema garments apply where completely different base garments (i.e. open toe, closed toe) or the same garment of differing compression sizes (i.e. Class 1, Class 2) are ordered.

8 Community Pharmacy News – May 2018

Only one prescription charge is payable if the base garments or compression sizes are the same (i.e. both open toe or both class 1). If the size (i.e. S, M, L, XL or I, II, III, IV, V) or length (i.e. standard, petite, short or long – not below knee or thigh high) or colour is different, this would still be one prescription charge regardless of quantity. 3. If an optional extra is prescribed with a lymphoedema garment on the same prescription, will an extra prescription charge apply? No, optional extras are classed as ‘no charge’ items. No additional fees or charges are payable because all that is being dispensed is the base garment with optional modifications. For example: Jobskin MTM Premium class 2 armsleeve lymphoedema garment FP0501-2 = 1 patient charge and 1 dispensing fee. Reimbursement is made for both the base garment and the optional extra at the Drug Tariff list price.

Look out for more frequently asked questions next month… If you would like more information on any of the topics covered, the team at PSNC will be happy to help (0203 1220 810 or e-mail





Prescription Submission Factsheet PSNC’s Dispensing and Supply Team highlights the key things to remember when endorsing and submitting prescriptions for payment, as well as sharing some of their top tips. End of day checks – tips from PSNC

   Pharmacy stamp must not obscure

   Double-check prescription

any patient details, prescribed items, or endorsements.    Items not dispensed must be endorsed ‘ND’ and a horizontal line drawn through the item not dispensed.    Exemption declarations must be completed in full where necessary to avoid prescriptions being switched between chargeable and nonchargeable. Signed declarations are required unless the patient is age exempt and their date of birth is computer-generated on the prescription.    Ensure that on EPS prescriptions any supplementary product information (e.g. a particular brand or manufacturer) is part of the prescribed product and NOT the dosage instructions, to ensure this is considered when calculating payment.    Separate any prescriptions to be filed in the red separator, such as:       expensive items (individual items with a net ingredient cost of £100 or more);

endorsements, checking for:      expensive items;       unlicensed specials/imports;       broken bulk (BB) claims; and       out of pocket (OOP) expenses.       You may find it useful to keep a record or copy of these for reconciliation later, especially for expensive items and unlicensed specials/imports.    Endorse only as needed – don’t over endorse as this can cause confusion and lead to incorrect reimbursement.    Endorse clearly keeping all endorsements within the left-hand side margin of the prescription form – can someone else clearly read the endorsement? If your PMR system endorses, is the printer ink clearly visible? Avoid any marks in the prescribing area of the form, e.g. ticks or endorsements, this may affect how the prescription is priced. Quantities owing should not be annotated on the prescription, this could be interpreted as the amount dispensed.

Preparing your submission bundle

This is how you need to arrange the prescriptions in the submission bundle:

     hand written amendments/ alterations by the prescriber;       unlicensed medicines/imports;       BB or OOP claims;       prescription forms containing items where the prescriber has provided additional information, e.g. preservative-free or sugar-free within the dosage instructions; and       where the prescriber’s signature touches or goes over the details of the last item on the prescription form.    Make sure all prescriptions are filed in the correct patient charge group – i.e. exempt, paid, old rate paid. Incorrectly filed prescriptions are a major cause of over payments.    Do not use labels or sticky notes on the form as residual glue can affect the scanning process. Pins, staples, paper clips, labels and invoices should also be removed prior to submission or these will have to be manually removed before pricing which can delay processing of your bundle.

Here are some examples of both good and bad practice:


D * Pharmacy teams must not submit EPS tokens where the patient is age exempt. A larger version of this diagram is available at: 9

10 Community Pharmacy News – May 2018

should be adjusted to include products that attract multiple fees, e.g. a HRT preparation with 3 fees would be counted as 3 items. Check the number of fees claimed on MDA instalment forms. See for more info.

above figures, ensure you tick the ‘EPS release 2 claim messages’ box and include the forms/items in the total numbers declared. Do not include the number of EPS tokens in the declaration as these are not used for calculating payment.

3   If you are submitting EPS release 2 reimbursement claims in the

of FP57 refund forms submitted and the value of the total amount refunded.

3   Include the number

your FP34C accurately and clearly – check numbers of forms/items (including EPS figures), MURs, AURs, NMS and staff hours are declared.

3   Ensure you complete

total forms/items to be declared, double-check your calculations – recording totals regularly this may simplify this stage, e.g daily/weekly records.

3   When calculating

date the form. Send to the Pricing Authority in a secure package and in a manner that ensures prescriptions don’t get mixed up in transit, via a track and trace method before the 5th day of the month following that in which supply was made. Keeping a copy of the form is recommended as a point of reference in case of a suspected error.

3   Stamp the form, complete the month where indicated, sign, print name and


3   For both paper and electronic prescriptions, the number of items declared

prescriptions, the figures should relate to the total number of electronic forms (not tokens) and items that have been dispensed in the month being claimed and submitted to the Pricing Authority via an electronic claim message by midnight on the 5th of the following month.

3   For electronic

prescriptions, declare the total number of forms and items physically included in the bundle (including returns).

3   For paper

Authority for that specific month to declare the combined total of paper and electronic prescriptions (items/forms) being submitted for reimbursement – each FP34C has a unique barcode, so you cannot use another contractor’s form if you do not have one. Contact the Pricing Authority as soon as possible if your FP34C was lost or not received.

3   Only use the barcoded FP34C document sent to you by the Pricing

Checklist for completing your FP34C






Drug Tariff Watch A quick summary of the changes due to take place from 1st June 2018. Part VIIIA additions Category A: •   Cimetidine 200mg tablets (60) •   *Dexamethasone 6.6mg/2ml solution for injection ampoules (10) •   Fludroxycortide 0.0125% cream SC (60g) Category C: •   Dronabinol 2.7mg/dose / Cannabidiol 2.5mg/dose oromucosal spray 270 dose (3xSC90) – Sativex •   Estradiol 100µg/24hours transdermal patches (4) – FemSeven 100 •   Estradiol 100µg/24hours transdermal patches (8) – Evorel 100 •   Estradiol 100µg/24hours transdermal patches (12) – Progynova TS •   Estradiol 100µg/24hours transdermal patches (24) – Estraderm MX 100 •   Estradiol 25µg/24hours transdermal patches (8) – Evorel 25 •   Estradiol 25µg/24hours transdermal patches (24) – Estraderm MX 25 •   Estradiol 37.5µg/24hours transdermal patches (8) – Estradot •   Estradiol 40µg/24hours transdermal patches (8) – Elleste Solo MX 40 •   Estradiol 50µg/24hours/Levonorgestrel 7µg/24hours transdermal patches (4) and (12) – FemSeven Conti •   Estradiol 50µg/24hours transdermal patches (4) and (12) – FemSeven 50 •   Estradiol 50µg/24hours transdermal patches (8) and (24) – Evorel 50 •   Estradiol 80µg/24hours transdermal patches (8) – Elleste Solo MX 80 •   Hyetellose 0.44% eye drops 0.5ml unit dose preservative free (20) – Minims artificial tears •   Ivermectin 10mg/g cream SC (30g) – Soolantra •   Lithium citrate 520mg/5ml oral solution sugar free (150ml) – Priadel •   Meloxicam 15mg orodispersible tablets sugar free (30) – Rhodes Pharma Ltd •   Meloxicam 7.5mg orodispersible tablets sugar free (30) – Rhodes Pharma Ltd •   Methadone 50mg/1ml solution for injection ampoules (10) – Physeptone •   Methadone 50mg/2ml solution for injection ampoules (10) – Physeptone •   Metronidazole 500mg suppositories (10) – Flagyl

•   Paliperidone 3mg MR tablets (28) – Invega •   Paliperidone 6mg MR tablets (28) – Invega •   Paliperidone 9mg MR tablets (28) – Invega •   Rufinamide 100mg tablets (10), 200 tablets (60) and 400mg tablets (60) – Inovelon •   Shingles (Herpes Zoster) vaccine (live) powder and solvent for suspension for injection 0.65ml pre-filled syringes SC (1) – Zostavax •   Sodium citrate 441.17mg/5ml oral solution SC (30ml) – Sodium citrate 0.3M •   Somatropin (rbe) 10mg/1.5ml solution for injection cartridges (5) – Omnitrope SurePal 10 •   Somatropin (rbe) 10mg/2ml solution for injection cartridges SC (1) and (3) – NutropinAq •   Somatropin (rbe) 15mg/1.5ml solution for injection cartridges (5) – Omnitrope SurePal 15 •   Somatropin (rbe) 5mg/1.5ml solution for injection cartridges (5) – Omnitrope SurePal 5

KEY: SC Special container R Item requiring reconstitution * This pack only (others already available)

•   Tacrolimus 1mg MR capsules SC (50) and (100) – Advagraf •   Tacrolimus 500µg MR capsules SC (50) – Advagraf •   Tobramycin 300mg/4ml nebuliser liquid ampoules (56) – Bramitob Part VIIIA deletions •   *Dexamethasone 6.6mg/2ml solution for injection ampoules (5) Category A •   Isotretinoin 0.05% gel (30g) Category C – zIsotrex •   Pholcodine 2mg/5ml oral solution sugar free (2000ml) Category C – Galenphol Paediatric •   *White soft paraffin 15% / Liquid paraffin light 6% cream (50g) and (1050ml) Category C – Oilatum For further changes, including amendments to Part VIIIA, please visit:

Part IX deletions Product

Type, Size, Product code

Hero H-2 multi-layer compression bandage kit


Hero H-2 Lite multi-layer compression bandage kit


Hero H-2 XL multi-layer compression bandage kit


Hero H-2 layer 1 bandage

10cm x 5m

Hero H-2 XL layer 2 bandage

10cm x 6m

Foley Catheter, 2 Way For Long Term Use - Adult, Covidien UK Commercial Ltd, Dover Silver (Male)

12-24Ch (605122IC605247IC)


15cm x 15cm


10cm x 13cm

WOUND MANAGEMENT DRESSINGS - KerraFibre, Rectangular 7cm x 5cm, 11cm x 9cm and 17cm x 11cm HYPODERMIC EQUIPMENT - Needles not less than 12mm

0.4mm (27G) - 0.5ml and 1.0ml syringe and needle

LYMPHOEDEMA GARMENTS - Juzo Expert, Custom made for the lower limb, Garter Belt

9100, 9120 and 9130

SUSPENSORY SYSTEMS - Teleflex, Rusch Belly Bag replacement belt


TWO PIECE OSTOMY SYSTEMS - Peak Medical Ltd – Combimate ileostomy bag with filer

Beige, Small, 38mm flange (ISBV238)

TWO PIECE OSTOMY SYSTEMS - Peak Medical Ltd – Combimate colostomy bag with filter

Small, 38mm flange (CSB238)

UROSTOMY BAGS - Peak Medical Ltd - Uromate

Pre-cut, 16mm (ULT116B) 11




PSNC resources library In this section of Community Pharmacy News we have provided details of some of the resources that PSNC has produced this month. PSNC Briefings PSNC Briefing 023/18: NHS mandate 2018/19 Every year, the Department of Health and Social Care (DHSC) issues a mandate to NHS England, to set out the Government’s objectives and requirements for NHS England to deliver, as well as its budget. This briefing summarises the elements that are of most relevance to community pharmacy. Download from: PSNC Briefing 025/18: Quality Payments – How to become a Healthy Living Pharmacy Level 1 This guidance provides an overview of how to achieve the Healthy Living Pharmacy criterion of the interim Quality Payments Scheme for the June 2018 review point. It has been revised since the 2017/18 version of the scheme.  Download from: PSNC Briefing 026/18: Quality Payments – Evidence checklist This checklist gives community pharmacy contractors examples of what constitutes acceptable evidence for meeting the gateway and quality criteria for the Quality Payments Scheme.  Download from: See all our PSNC Briefings in our database at:

Other resources Complying with GDPR webinar A recording of PSNC’s webinar on the General Data Protection Regulation (GDPR) is now available. During the webinar PSNC Director of Operations and Support, Gordon Hockey, explained what the GDPR means for the average pharmacy business and outlined the steps contractors will need to take to comply.  Watch now: Quality Payments Scheme video Zainab Al-Kharsan, Service Development Pharmacist at PSNC, has recorded a six-minute video presentation summarising the changes that have been made for the June 2018 review point of the Quality Payments Scheme.  Watch now: Look out for additional resources as you explore our website:

Email news alerts Quality Payments: New NHS England guidance published (30th April) Informing community pharmacy contractors of the publication of NHS England’s guidance on the June 2018 review point of the Quality Payments Scheme, whilst also highlighting the resources that PSNC had published alongside this documentation.  Read now: Not receiving our emails? Sign up now at: PSNC website For up to date information and news on community pharmacy issues, visit the PSNC website at PSNC Community Pharmacy News is published by: The Pharmaceutical Services Negotiating Committee, 14 Hosier Lane, London, EC1A 9LQ Community Pharmacy News is edited by: Melinda Mabbutt who can be contacted at the above address or by email at: PSNC Office: 0203 122 0810


May 2018 CPN  
May 2018 CPN